Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence‐Based Expert Review
International Forum of Allergy & Rhinology · 2026-08 · 16 (8) · 852-879
DOI: 10.1002/alr.70211 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Forum of Allergy & Rhinology, online erschienen am 06.07.2026. Verfasst von Andrew Thamboo und 28 weiteren Autor:innen. Beteiligte Einrichtung: Otolaryngology-Head & Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Rhinosinusitis, Adrenal Cortex Hormones, Nasal Polyps, Anti-Inflammatory Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Chronic rhinosinusitis (CRS) is a prevalent, heterogeneous inflammatory disease associated with significant morbidity. Systemic corticosteroids (SCS) are commonly prescribed for their anti‐inflammatory effects, but cumulative exposure carries risks, including metabolic, cardiovascular, and skeletal complications. Despite widespread use, evidence‐based guidance on optimal indications, timing, and duration of SCS in CRS remains inconsistent. Methodology/Principal An evidence‐based review was performed using MEDLINE, EMBASE, and Cochrane databases (2013–2023). Studies were screened and categorized into two primary groups: CRS with (CRSwNP) or without (CRSsNP) nasal polyps. Within CRSwNP, evidence was subcategorized by indication, including (1) polyp size reduction, (2) olfactory dysfunction, (3) comorbid disease, and (4) perioperative use, encompassing pre‐ and postoperative SCS administration. The CRSsNP category included studies evaluating SCS in non‐polypoid disease, with or without comorbidities. Recommendations were graded according to evidence quality and the balance of benefit versus harm.
Results
Short courses of SCS provide consistent, short‐term improvements in nasal polyp size, nasal congestion, and olfactory function in CRSwNP, but benefits wane within weeks unless followed by intranasal corticosteroids. Preoperative SCS improves intraoperative visualization, though comparable nonsteroidal techniques exist. Routine postoperative SCS are not supported, showing no meaningful advantage over topical therapy. No additional benefit was seen in comorbid subgroups. Evidence in CRSsNP is limited, with possible benefit only in early disease or select medically managed cases. Repeated use contributes to cumulative toxicity.
Conclusions
SCS have a narrow, time‐limited role in CRS. Stewardship should emphasize optimized topical therapy, appropriate sinus surgery, and biologics to minimize systemic steroid exposure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Otolaryngology-Head & Neck Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
- Otorhinolaryngology-Department of Medicine and Surgery, University of Perugia, Perugia, Italy.
- Otolaryngology-Head and Neck Surgery, Harvard Medical School, Boston, Massachusetts, USA.
- Otolaryngology-Head and Neck Surgery, Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, Massachusetts, USA.
- Otolaryngology-Head & Neck Surgery, Dalhousie University, Halifax, Nova Scotia, Canada.
- Oto-rhino-laryngologie, Chirurgie Cervico-faciale, CHU De Québec, Université Laval, Quebec City, Quebec, Canada.
ORCID-Profile: Eugenio De Corso, Claire Hopkins, Peter H Hwang, Daniel Lee, Amber Luong, Zara M Patel, Leigh Sowerby, Martin Wagenmannm, Quirina Thompson, Martin Desrosiers
Zitieren
APA
Thamboo, A., Gigliotti, D., De Corso, E., Lee, S., Bleier, B. S., Chin, C. J., Corriveau, M. N., Hox, V., Hopkins, C., Hwang, P. H., Janjua, A., Klimek, L., Lee, D., Lee, J., Luong, A., Mortuaire, G., Mullol, J., Patel, Z. M., Scott, J., …, & Chan, Y. (2026). Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence‐Based Expert Review. International Forum of Allergy & Rhinology, 16(8), 852-879. https://doi.org/10.1002/alr.70211
Vancouver
Thamboo A, Gigliotti D, De Corso E, Lee S, Bleier BS, Chin CJ, et al. Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence‐Based Expert Review. International Forum of Allergy & Rhinology. 2026;16(8):852-879. doi:10.1002/alr.70211
BibTeX
@article{Thamboo2026,
author = {Thamboo, Andrew and Gigliotti, Deanna and De Corso, Eugenio and Lee, Stella and Bleier, Benjamin S and Chin, Christopher J and Corriveau, Marie-Noelle and Hox, Valerie and Hopkins, Claire and Hwang, Peter H and Janjua, Arif and Klimek, Ludger and Lee, Daniel and Lee, John and Luong, Amber and Mortuaire, Geoffrey and Mullol, Joaquim and Patel, Zara M and Scott, John and Sommer, Doron and Sowerby, Leigh and Tewfik, Marc and Voizard, Beatrice and Wagenmannm, Martin and Wise, Sarah K and Yip, Jonathan and Thompson, Quirina and Desrosiers, Martin and Chan, Yvonne},
title = {Systemic Corticosteroids in the Management of Sinonasal Disease: An Evidence‐Based Expert Review},
journal = {International Forum of Allergy & Rhinology},
year = {2026},
volume = {16},
number = {8},
pages = {852--879},
doi = {10.1002/alr.70211}
}
EUVIMED